Ganglioneuroma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:251992D36.1
Who is this for?
Show terms as
7Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Ganglioneuroma is a rare, benign tumor arising from neural crest cells, composed of mature ganglion cells, Schwann cells, and nerve fibers. It belongs to the spectrum of neuroblastic tumors, which also includes neuroblastoma (malignant) and ganglioneuroblastoma (intermediate). Ganglioneuromas represent the most differentiated and benign end of this spectrum. These tumors most commonly develop in the posterior mediastinum (chest), retroperitoneum (abdomen), adrenal glands, and along the sympathetic chain, though they can occur anywhere sympathetic nervous tissue is present, including the neck and pelvis. Many ganglioneuromas are discovered incidentally on imaging studies performed for other reasons, as they often grow slowly and remain asymptomatic for extended periods. When symptoms do occur, they are typically related to the mass effect of the tumor on surrounding structures and may include abdominal pain, back pain, or a palpable mass. In some cases, ganglioneuromas may be hormonally active, secreting catecholamines or vasoactive intestinal peptide (VIP), leading to symptoms such as diarrhea, sweating, or hypertension. Rarely, spinal cord compression can occur if the tumor extends into the spinal canal (dumbbell-shaped tumors). Ganglioneuromas are most frequently diagnosed in children, adolescents, and young adults, with a slight female predominance reported in some series. The primary treatment is surgical excision, which is generally curative. Complete resection is associated with an excellent prognosis, and recurrence is rare. In cases where complete removal is not feasible due to the tumor's location or involvement of critical structures, observation with serial imaging may be appropriate, as these tumors have no metastatic potential. Some ganglioneuromas may arise from spontaneous maturation of neuroblastoma, particularly in younger children. No chemotherapy or radiation therapy is typically required for pure ganglioneuromas.

Clinical phenotype terms— hover any for plain English:

GanglioneuromaHP:0003005Abnormality of the adrenal glandsHP:0000834Multiple intestinal neurofibromatosisHP:0005220Abnormal mediastinum morphologyHP:0045026Colorectal polyposisHP:0200063Hamartomatous polyposisHP:0004390Functional intestinal obstructionHP:0005249Neoplasm of the adrenal glandHP:0100631Abnormality of the orbital regionHP:0000315Abnormal rectum morphologyHP:0002034Abnormal bone structureHP:0003330Central hypoventilationHP:0007110Abnormal prostate morphologyHP:0008775
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Childhood to adulthood

Can begin any time from childhood through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Ganglioneuroma.

View clinical trials →

No actively recruiting trials found for Ganglioneuroma at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Ganglioneuroma community →

Specialists

7 foundView all specialists →
DM
Debra E Weese-Mayer, MD
CHICAGO, IL
Specialist
PI on 2 active trials
DH
Douglas S Hawkins
Birmingham, Alabama
Specialist

Rare Disease Specialist

PI on 2 active trials17 Ganglioneuroma publications
GM
Giles W. Robinson, MD
MEMPHIS, TN
Specialist
PI on 4 active trials1 Ganglioneuroma publication
NM
Nadia Laack, MD
ROCHESTER, MN
Specialist
PI on 1 active trial
FM
Francois Benard, MD
Specialist
PI on 3 active trials
KM
Karen Gauvain, M.D.
Specialist
PI on 1 active trial
AM
Anna Vinitsky, MD, MS
MEMPHIS, TN
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Ganglioneuroma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open GanglioneuromaForum →

No community posts yet. Be the first to share your experience with Ganglioneuroma.

Start the conversation →

Latest news about Ganglioneuroma

No recent news articles for Ganglioneuroma.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Ganglioneuroma

What is Ganglioneuroma?

Ganglioneuroma is a rare, benign tumor arising from neural crest cells, composed of mature ganglion cells, Schwann cells, and nerve fibers. It belongs to the spectrum of neuroblastic tumors, which also includes neuroblastoma (malignant) and ganglioneuroblastoma (intermediate). Ganglioneuromas represent the most differentiated and benign end of this spectrum. These tumors most commonly develop in the posterior mediastinum (chest), retroperitoneum (abdomen), adrenal glands, and along the sympathetic chain, though they can occur anywhere sympathetic nervous tissue is present, including the neck a

How is Ganglioneuroma inherited?

Ganglioneuroma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Ganglioneuroma typically begin?

Typical onset of Ganglioneuroma is childhood to adulthood. Age of onset can vary across affected individuals.

Which specialists treat Ganglioneuroma?

7 specialists and care centers treating Ganglioneuroma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.